A Randomised, Double-blind, Placebo-controlled, Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treatment With Single and Repeat Doses of Inhaled RV568 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2013
At a glance
- Drugs RV 568 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Seasonal allergic rhinitis
- Focus Adverse reactions
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Sep 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.